These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26889404)

  • 1. Smads as therapeutic targets for chronic kidney disease.
    Lan HY
    Kidney Res Clin Pract; 2012 Mar; 31(1):4-11. PubMed ID: 26889404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
    Lan HY
    Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β/Smad signaling in renal fibrosis.
    Meng XM; Tang PM; Li J; Lan HY
    Front Physiol; 2015; 6():82. PubMed ID: 25852569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
    Lan HY
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β/Smad signaling in kidney disease.
    Lan HY; Chung AC
    Semin Nephrol; 2012 May; 32(3):236-43. PubMed ID: 22835454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
    Yang F; Chung AC; Huang XR; Lan HY
    Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
    Meng XM; Chung AC; Lan HY
    Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse Role of TGF-β in Kidney Disease.
    Gu YY; Liu XS; Huang XR; Yu XQ; Lan HY
    Front Cell Dev Biol; 2020; 8():123. PubMed ID: 32258028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chung AC; Qin W; Chen HY; Lan HY
    Kidney Int; 2012 Feb; 81(3):266-79. PubMed ID: 22048127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis.
    Chung AC; Huang XR; Meng X; Lan HY
    J Am Soc Nephrol; 2010 Aug; 21(8):1317-25. PubMed ID: 20488955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad7 as a therapeutic agent for chronic kidney diseases.
    Lan HY
    Front Biosci; 2008 May; 13():4984-92. PubMed ID: 18508563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation.
    Liu Z; Huang XR; Chen HY; Fung E; Liu J; Lan HY
    Hypertension; 2017 Oct; 70(4):822-830. PubMed ID: 28808068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
    Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
    Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.
    Liu GX; Li YQ; Huang XR; Wei L; Chen HY; Shi YJ; Heuchel RL; Lan HY
    PLoS One; 2013; 8(1):e53573. PubMed ID: 23301086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
    Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
    Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis.
    Feng M; Tang PM; Huang XR; Sun SF; You YK; Xiao J; Lv LL; Xu AP; Lan HY
    Mol Ther; 2018 Jan; 26(1):148-161. PubMed ID: 29102563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα.
    Lyu H; Li X; Wu Q; Hao L
    J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.